Digital Tech Convergence Is Transforming Health Care - LSX Panel

19 Sep 2024

Leaders from Eli Lilly and Vertex Pharmaceuticals, 9amHealth, Features Capital, and accelerator PharmStars discussed the convergence of biopharma, medtech and healthtech, and what is needed to achieve health care transformation, in an LSX World Congress USA panel.

The rising convergence of biopharma, medtech and healthtech, which have traditionally been separate entities, is anticipated to modernize health care, drive innovation and improve health care. During the recent LSX World Congress USA in Boston, leaders from big pharma, biotech, venture capital, telemedicine, and consulting discussed opportunities and challenges in bringing together stakeholders to create change.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

Start your 7-day free trial
Explore trusted news, analysis, and insights
Access comprehensive global coverage
Enjoy instant access – no credit card required

Start Free Trial

Already a subscriber?

Empowering Primary Care Physicians With Digital Biomarkers For Early Alzheimer’s Detection

27 Sep 2024

• By Marion Webb

Altoida CEO Mark Jones has high hopes that the company’s digital assessment tool will be approved by the FDA to be used along with blood biomarker testing by primary care doctors to help predict Alzheimer’s disease before patients show symptoms.

Altoida’s Vision For Alzheimer’s Care Combines Digital Screening, Blood-Based Tests, New Drugs

27 Sep 2024

• By Marion Webb

Altoida CEO Marc Jones spoke with Medtech Insight about the company’s investigational digital screening tool for Alzheimer’s and the dire need for better, more accessible precision neurology diagnostics as the global population ages, neurologist shortages worsen, and groundbreaking Alzheimer’s drugs change the treatment paradigm.